Derek C Angus,Alison J Huang,Roger J Lewis,Amy P Abernethy,Robert M Califf,Martin Landray,Nancy Kass,Kirsten Bibbins-Domingo,JAMA Summit on Clinical Trials Participants,Ali B Abbasi,Kaleab Z Abebe,Stacey J Adam,Jamy Ard,Rachel A Bender Ignacio,Scott M Berry,Deepak L Bhatt,Robert O Bonow,Marc Bonten,Sharon A Brangman,John Brownstein,Melinda J B Buntin,Atul J Butte,Marion K Campbell,Anne R Cappola,Anne C Chiang,Deborah Cook,Steven R Cummings,Gregory Curfman,Laura J Esserman,Lee A Fleisher,Joseph B Franklin,Ralph Gonzalez,Cynthia I Grossman,Tufia C Haddad,Roy S Herbst,Adrian F Hernandez,Diane P Holder,Leora Horn,Grant D Huang,Alison Huang,Rohan Khera,Walter J Koroshetz,Harlan M Krumholz,Tracy A Lieu,Preeti N Malani,Christa Lese Martin,Mark McClellan,Mary M McDermott,Stephanie R Morain,Susan A Murphy,Stuart G Nicholls,Stephen J Nicholls,Peter J O'Dwyer,Bhakti K Patel,Eric Peterson,Sheila A Prindiville,Joseph S Ross,Kathryn M Rowan,Gordon Rubenfeld,Christopher W Seymour,Rod S Taylor,Joanne Waldstreicher,Tracy Y Wang

Abstract:Importance: Optimal health care delivery, both now and in the future, requires a continuous loop of knowledge generation, dissemination, and uptake on how best to provide care, not just determining what interventions work but also how best to ensure they are provided to those who need them. The randomized clinical trial (RCT) is the most rigorous instrument to determine what works in health care. However, major issues with both the clinical trials enterprise and the lack of integration of clinical trials with health care delivery compromise medicine's ability to best serve society. Observations: In most resource-rich countries, the clinical trials and health care delivery enterprises function as separate entities, with siloed goals, infrastructure, and incentives. Consequently, RCTs are often poorly relevant and responsive to the needs of patients and those responsible for care delivery. At the same time, health care delivery systems are often disengaged from clinical trials and fail to rapidly incorporate knowledge generated from RCTs into practice. Though longstanding, these issues are more pressing given the lessons learned from the COVID-19 pandemic, heightened awareness of the disproportionate impact of poor access to optimal care on vulnerable populations, and the unprecedented opportunity for improvement offered by the digital revolution in health care. Four major areas must be improved. First, especially in the US, greater clarity is required to ensure appropriate regulation and oversight of implementation science, quality improvement, embedded clinical trials, and learning health systems. Second, greater adoption is required of study designs that improve statistical and logistical efficiency and lower the burden on participants and clinicians, allowing trials to be smarter, safer, and faster. Third, RCTs could be considerably more responsive and efficient if they were better integrated with electronic health records. However, this advance first requires greater adoption of standards and processes designed to ensure health data are adequately reliable and accurate and capable of being transferred responsibly and efficiently across platforms and organizations. Fourth, tackling the problems described above requires alignment of stakeholders in the clinical trials and health care delivery enterprises through financial and nonfinancial incentives, which could be enabled by new legislation. Solutions exist for each of these problems, and there are examples of success for each, but there is a failure to implement at adequate scale. Conclusions and relevance: The gulf between current care and that which could be delivered has arguably never been wider. A key contributor is that the 2 limbs of knowledge generation and implementation-the clinical trials and health care delivery enterprises-operate as a house divided. Better integration of these 2 worlds is key to accelerated improvement in health care delivery.

Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition

Advancing Global Health Equity in Oncology Clinical Trial Access

Global adoption of remote technologies to enable patient-centric oncology clinical trials: Analysis by the Bloomberg New Economy International Cancer Coalition.

Remote Monitoring and Data Collection for Decentralized Clinical Trials

A call to action to advance patient‐focused and decentralized clinical trials

Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement

Creating Partnerships to Optimize Quality Cancer Care

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective

Turning the Tide Against Cancer Through Sustained Medical Innovation: The Pathway to Progress

Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers

A Vision for Democratizing Next-Generation Oncology Clinical Trials

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided

Advancing Digital Health Innovation in Oncology: Priorities for High-Value Digital Transformation in Cancer Care

Publicly Funded Clinical Trials and the Future of Cancer Care

A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies

Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021

Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG

Accelerating Cancer Omics and Precision Oncology in Health Care and Research: a Lancet Oncology Commission

Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally

The European Cancer Patient Coalition and its central role in connecting stakeholders to advance patient-centric solutions in the mission on cancer